CONTACT

SITEMAP

HOME

better antibody

NEWS

PRESS RELEASES

04.26.13: Monoclonal Antibody with Xencor’s High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia

ARTICLES

Signs of ma(b)turity: BioCentury

CALENDAR

No events at this time.

Contact

Phone

Tel: 626-305-5900
Fax: 626-305-0350

E-mail

info@xencor.com
busdev@xencor.com
recruiting@xencor.com

Address

Xencor
111 West Lemon Avenue
Monrovia CA 91016

R&D PROGRAMS

proteins by design

XmAb^® TECHNOLOGY

VIEW OUR PIPELINE

VIEW OUR PARTNERS